These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 91538)

  • 61. Autoantibodies to insulin and to proinsulin in type 1 diabetic patients and in at-risk probands differentiate only little between both antigens.
    Keilacker H; Rjasanowski I; Besch W; Kohnert KD
    Horm Metab Res; 1995 Feb; 27(2):90-4. PubMed ID: 7538970
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A method for determination of proinsulin levels in serum using both insolubilized anti-insulin antibody and anti-C-peptide antibody].
    Sasakuma F; Hasegawa K; Ishikawa O; Matumiya K; Yagi K; Kitamura H; Kojima J
    Rinsho Byori; 1992 Jul; 40(7):769-74. PubMed ID: 1507496
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia.
    Cohen RM; Given BD; Licinio-Paixao J; Provow SA; Rue PA; Frank BH; Root MA; Polonsky KS; Tager HS; Rubenstein AH
    Metabolism; 1986 Dec; 35(12):1137-46. PubMed ID: 3023795
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies.
    Kjems LL; Røder ME; Dinesen B; Hartling SG; Jørgensen PN; Binder C
    Clin Chem; 1993 Oct; 39(10):2146-50. PubMed ID: 8403400
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of proinsulin and insulin in the diagnosis of insulinoma: a critical evaluation of the Endocrine Society clinical practice guideline.
    Guettier JM; Lungu A; Goodling A; Cochran C; Gorden P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4752-8. PubMed ID: 24081736
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Presumed insulinoma secreting a high-molecular-weight insulin analogue.
    Nunes-Correa J; Lowy C; Sönksen PH
    Lancet; 1974 May; 1(7862):837-41. PubMed ID: 4132792
    [No Abstract]   [Full Text] [Related]  

  • 67. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 68. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
    Vangipurapu J; Stančáková A; Kuulasmaa T; Kuusisto J; Laakso M
    PLoS One; 2015; 10(4):e0124028. PubMed ID: 25853252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
    Coifman R; Dalbosco IS; Russo EM; Moisés RS
    Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Micromodification of an immunoradiometric assay for proinsulin.
    Sopwith AM; Hales CN
    Ann Clin Biochem; 1980 Jul; 17(4):185-7. PubMed ID: 7425512
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A unique form of circulating insulin in human islet cell carcinoma.
    Gorden P; Freychet P; Nankin H
    J Clin Endocrinol Metab; 1971 Dec; 33(6):983-7. PubMed ID: 4332614
    [No Abstract]   [Full Text] [Related]  

  • 73. [Measurement of proinsulin, insulin and C-peptide in human blood by high performance liquid chromatography].
    Povazhenko AA; Ryzhova TI; Kozyreva EV
    Klin Lab Diagn; 1997 Sep; (9):34-6. PubMed ID: 9377023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients.
    Kruszynska YT; Harry DS; Mohamed-Ali V; Home PD; Yudkin JS; McIntyre N
    Metabolism; 1995 Feb; 44(2):254-60. PubMed ID: 7869924
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors.
    Deberg M; Houssa P; Frank BH; Sodoyez-Goffaux F; Sodoyez JC
    Clin Chem; 1998 Jul; 44(7):1504-13. PubMed ID: 9665430
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin.
    Faber OK; Markussen J; Naithani VK; Binder C
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):751-7. PubMed ID: 986357
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme.
    Kitabchi AE; Duckworth WC; Brush JS; Heinemann M
    J Clin Invest; 1971 Sep; 50(9):1792-9. PubMed ID: 4327576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
    Pradhan AD; Manson JE; Meigs JB; Rifai N; Buring JE; Liu S; Ridker PM
    Am J Med; 2003 Apr; 114(6):438-44. PubMed ID: 12727576
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma proinsulin in patients with functioning pancreatic islet cell tumors.
    Sherman BM; Pek S; Fajans SS; Floyd JC; Conn JW
    J Clin Endocrinol Metab; 1972 Aug; 35(2):271-80. PubMed ID: 4342038
    [No Abstract]   [Full Text] [Related]  

  • 80. Elevated serum proinsulin in beta cell nesidioblastosis. Report of a case in a newborn.
    Kühl C; Hvorslev V; Tygstrup I; Lindkaer Jensen S
    Scand J Gastroenterol Suppl; 1979; 53():49-52. PubMed ID: 225788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.